España
India
Italia
대한민ęµ
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민ęµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Recent
Markets
Brian Wright
22nd Century Group Reports Q1 Net Sales Of $9M, Up 33% YoY, Net Loss Also Grows
Sterne Agee Says Aetna's Growth Prospects Are Strong
Sterne Agee Analyst Sees Little Upside For UnitedHealth Group
Sterne Agee Says Aetna's Growth Prospects Are Strong
Sterne Agee Analyst Sees Little Upside For UnitedHealth Group
Sterne Agee: Hospitals Face Trading Risk In Obamacare Case
Sterne Agee: Tough Flu Season Helps Hospitals, Hurts Insurers
Sterne Agee: Hospitals Face Trading Risk In Obamacare Case
|
Sterne Agee: Tough Flu Season Helps Hospitals, Hurts Insurers
|
Sterne Agee Sees Opportunities With Latest Obamacare Court Challenge
|
Sterne Agee Previews Q3 Earnings For Medicaid Plans
|
Read More...
Brian Wright Recent News
Sterne Agee Lowers Rating On Cigna
|
UPDATE: Sterne Agee Upgrades WellCare Health Plans
|
UPDATE: Sterne Agee Reiterates On UnitedHealth Group On Raised Estimates, Less Near-Term Upside
|
UPDATE: Sterne Agee Initiates Coverage On Molina Healthcare As Mean Reversion Is Underway
|
UPDATE: Sterne Agee Initiates Coverage On WellCare Health Plans As Potential Partners Could Dance Elsewhere
|
UPDATE: Sterne Agee Initiates Coverage On Aetna On Less Earnings Power Upside Potential
|
UPDATE: Sterne Agee Initiates Coverage On UnitedHealth On Recent Rough Spell
|
UPDATE: Sterne Agee Initiates Coverage On WellPoint On Positive Bias
|
UPDATE: Sterne Agee Initiates Coverage On Centene As Premium Performance Deserves Premium Multiple
|